🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to look at the pharmacokinetics of a new formu...
Status
Completed
Location
Algorithme Pharma Inc.
Start Date
2015-06
Trial ID
NCT02465489
Treatments Being Tested
Tapentadol is FDA approved for the treatment of moderate to severe acute pa...
Status
Completed
Location
Mayo Clinic in Rochester
Start Date
2011-05
Trial ID
NCT01500317
Treatments Being Tested
This study was a double-blind, randomized, parallel group, proof of concept...
Status
Terminated
Location
San Antonio Military Medical Center
Start Date
2015-02
Trial ID
NCT02468583
Treatments Being Tested
This is a Phase 1, Single-Centre, Open-Label, Two-Part, Sequential Cross-Ov...
Status
Completed
Location
GSK Investigational Site
Start Date
2022-10-07
Trial ID
NCT05570539
Treatments Being Tested
The purpose of the study is to evaluate the pharmacokinetics (PK), safety, ...
Status
Completed
Location
Quotient Sciences
Start Date
2020-10-02
Trial ID
NCT04580797
Treatments Being Tested
This is a phase 3, multicentre, prospective, single-blind on principal effi...
Status
Unknown
Location
Hôpital Roger Salengro
Start Date
2018-12-19
Trial ID
NCT03902340
Treatments Being Tested
This study is an open-label, single dose, randomized, 5-period, 5-treatment...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2012-03
Trial ID
NCT01443169
Treatments Being Tested
Initial studies have used a powder in capsule formulation of PH797804. In f...
Status
Withdrawn
Location
Multiple Locations
Start Date
2009-02
Trial ID
NCT00827515
The study will try, in 2 separate parts, each using 12 research subjects, t...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2009-01
Trial ID
NCT00838058
Treatments Being Tested
The purpose of this study is to compare the pharmacokinetics (PK) profiles ...
Status
Completed
Location
Parexel International
Start Date
2012-06
Trial ID
NCT01686217
Treatments Being Tested